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Tse2 is a cytoactive toxin secreted by a type six
secretion apparatus of Pseudomonas aeruginosa.
The Tse2 toxin naturally attacks a target in the cyto-
plasm of bacterial cells, and can cause toxicity if ar-
tificially introduced into eukaryotic cells. The X-ray
crystal structure of the complex of Tse2 and its
cognate immunity protein Tsi2 revealed a heterote-
trameric structure with an extensive binding inter-
face. Structural identity was found between Tse2
and NAD-dependent enzymes, especially ADP-ribo-
sylating toxins, which facilitated the identification of
the Tse2 active site and revealed it to be occluded
upon binding the inhibitor Tsi2. The structural
identity shared with NAD-dependent enzymes,
including conserved catalytic residues, suggests
that the mechanism of Tse2 toxicity may be NAD
dependent.INTRODUCTION
Gram-negative bacteria employ type six secretion systems
(T6SS) to transfer effector molecules, often toxins, to adjacent
bacteria and host cells (Ho et al., 2014). Many of the character-
ized T6SS toxins target competing bacteria, although there are
also examples of eukaryotic targeting (Hood et al., 2010; Jiang
et al., 2014). Gene clusters encoding T6SSs are found widely
in the genomes of both pathogenic and environmental Gram-
negative bacteria (Boyer et al., 2009). Secretion systems that
are involved in targeting bacteria are primarily involved in
maintaining competitive fitness in polymicrobial communities,
but may also function as signaling systems (Russell et al.,
2014).
The T6SS is analogous to a contractile phage-tail complex that
is attached to the bacterial inner membrane and injects effectors
into adjacent cells (Basler and Mekalanos, 2012; Leiman et al.,
2009). Secretion is thought to be driven by a two-component
contractile tube of TssB and TssC that provides energy to force
the needle tip, needle body, and associated effectors through
the membrane complex of the donor cell and into the target
cell (Basler et al., 2012; Clemens et al., 2015). Secretion of an
effector molecule is dependent on an interaction with either theStructure 24, 27putative needle tip complex made of VgrG and PAAR-repeat
proteins or the ring-shaped needle body protein Hcp (Shneider
et al., 2013; Silverman et al., 2013).
Pseudomonas aeruginosa, an opportunistic pathogen, is a
model organism for the study of the T6SS and its effectors.
The first three discovered secreted substrates from the H1-
T6SS from P. aeruginosa are translocated into competing bacte-
rial cells, resulting in death of the recipients (Hood et al., 2010;
Russell et al., 2011). Each of these toxins has an associated im-
munity protein, termed type six immunity (referred to as Tsi 1
through 3), which protects P. aeruginosa from self-intoxication
or sister cell intoxication (Russell et al., 2011, 2014). Type six
effectors Tse 1 and 3 are hydrolases that degrade the peptido-
glycan layer of neighboring bacteria (Russell et al., 2011). Ectop-
ically expressed Tse2 has been shown to be toxic to yeast and
mammalian cells, but the toxic effect of Tse2 directly from
P. aeruginosa has only been observed against other bacteria
(Hood et al., 2010). The toxic activity of Tse2 is directed toward
the cytoplasmic compartment of targeted bacterial cells (Li et al.,
2012), indicating that the toxin has to cross the two membranes
of both the attacking and targeted cell.
Tse2 shares no sequence identity with any protein of known
function and, although the structure of its immunity protein is
known, the structure and molecular mechanism of Tsi2 inhibi-
tion of Tse2 are unknown. Here, the X-ray crystal structure of
the complex of Tse2 and Tsi2 reveals the molecular me-
chanism of inhibition. The structure of Tse2 also led to the dis-
covery of unique structural features that differentiate this
cytoactive toxin from the other structurally characterized toxins
that are active in the periplasm. Structural identity with bacte-
rial ADP-ribosyltransferase toxins, which informed structure-
guided mutagenesis, provided critical insight into the active
site of Tse2.RESULTS
Structure of the Tse2/Tsi2 Complex
Co-expression of the P. aeruginosa tse2 and tsi2 genes in
Escherichia coli allowed the production and purification of
the protein complex, the structure of which was determined
to a resolution of 2.4 A˚ by molecular replacement using the
structure of Tsi2 as a search model (Table 1). The asymmetric
unit contained a single heterotetramer comprising two mole-
cules each of Tse2 and Tsi2 (Figure 1A). At the core of the
tetramer is a dimer of Tsi2 (Figure 1A), with the two identical7–284, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 277
Table 1. Data Collection and Structural Refinement Statistics
PaTse2Tsi2
Data Collection
Beamline SSRL 12-2
Wavelength (A˚) 1.000
Temperature (K) 100
Resolution (A˚)a 38.34–2.40 (2.53–2.40)
Space group P212121
Unit cell dimensions
a, b, c (A˚) 37.72, 103.14, 114.64
Rmerge 0.089 (0.732)
I/sI 13.4 (2.3)
Completeness (%) 97.6 (99.1)
Redundancy 4.0 (4.2)
Refinement
Resolution (A˚) 35.83–2.40
No. of reflections 16,778
Model contents A: Tsi2 (2–75)
B: Tsi2 (1–75)
C: Tse2 (3–158, D38–40)
D: Tse2 (3–158, D38–40)
Rwork/Rfree 0.20/0.25
No. of atoms
Protein 3,437
Water 74
B factors
Overall 41.9
Protein 43.5
Water 37.6
Rmsd
Bond lengths (A˚) 0.015
Bond angles () 1.568
Ramachandran plot (%)
Most favored 97
Outliers 0.93
PDB accession code 5AKO
aValues in parentheses correspond to the highest-resolution shell (2.53–
2.40 A˚).surfaces on either side of the Tsi2 dimer forming binding sites
for Tse2 monomers, resulting in a heterotetrameric complex
having C2 symmetry. Comparison of the Tsi2 dimer in the com-
plex with existing structures of Tsi2 (PDB: 3STQ, 3RQ9, and
3VPV) gives a root-mean-square deviation (rmsd) of 0.98–
1.27 A˚ (Li et al., 2012; Zou et al., 2012), implying that Tsi2
does not undergo any significant conformational changes
upon binding to Tse2.
The symmetry and compact nature of the heterotetrameric
complex making up the contents of the asymmetric unit sug-
gests that this is a natural and stable multimer. To provide addi-
tional support for this, we performed a more detailed analysis of
the interfaces making up the complex using PISA (Krissinel and
Henrick, 2007). Overall, five interfaces are involved in forming the
heterotetramer: one forming the dimer interface for Tsi2 and two278 Structure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All ridentical sets of two interfaces mediating the interaction of the
two Tse2molecules with the Tsi2 dimer. The Tsi2 dimer interface
is 818 A˚2, which is roughly 15% of the total Tsi2 monomer
surface area, and is predicted to have a binding energy of
19.3 kcal/mol. The interface of the Tsi2 dimer with a Tse2
monomer displays charge complementarity (Figure 1B) and
this binding surface, which involves both Tsi2 molecules, can
be divided into two regions whereby each monomer of the Tsi2
dimer has an interface with the one Tse2 molecule (Figure 1C).
The larger interface, which we refer to as the primary interface,
occurs between the b sheet of Tse2 and a helix 2 of Tsi2 (i.e. be-
tween chain C of Tse2 and chain B of Tsi2, and between chain D
of Tse2 and chain A of Tsi2). This interface comprises 658 A˚2 of
surface area (12% of the total Tse2 surface area) and is pre-
dicted to have a binding energy of 11.2 kcal/mol. Consistent
with this large predicted binding energy is the formation of five
hydrogen bonds as well as salt bridges between three residues
on the basic surface of Tse2 (Arg-89, Arg-90, and Arg-119) and
three on the acidic surface of Tsi2 (Glu-38, Asp-45, and Asp-
49) (Figure 1D). Indeed, supporting the importance of the ionic
component of this interface, Li et al. mutated Asp-45 and Glu-
38 in Tsi2, which pair with Arg-119 and Arg-90, respectively, in
Tse2, and this abrogated binding of Tsi2 and Tse2 in vitro and
eliminated the ability of Tsi2 to detoxify Tse2 in cell-based
assays (Li et al., 2012).
The secondary interface is formed by the extended loop of
Tse2 enveloping the N and C termini of the second Tsi2 mole-
cule in the Tsi2 dimer (i.e. between chain C of Tse2 and chain
A of Tsi2, and between chain D of Tse2 and chain B of Tsi2).
This interface comprises 616 A˚2 of surface area (11% of
the total Tse2 surface area) with 14 hydrogen bonds, and is
predicted to have a binding energy of 8.7 kcal/mol (Fig-
ure 1E). Thus, the total interface between a single Tse2 mole-
cule and the Tsi2 dimer is substantial at 1,274 A˚2 (24% of the
total Tse2 surface area is buried at the interface) with a large
number of specific intermolecular interactions (i.e. hydrogen
bonds and salt bridges), all of which is consistent with the ho-
motetramer observed in the asymmetric unit being an explicit
biological assembly. Furthermore, the complete heterote-
tramer as it occurs in the asymmetric unit is predicted to be
very stable with a Gibbs free energy of dissociation of
23 kcal/mol, which again supports a multimeric structure that
is specific and not an assembly that is driven by the formation
of a crystal lattice.
The Structure of Tse2
The structure of Tse2 from the complex comprises an anti-paral-
lel five-stranded b sheet with strands in the order of 3-1-2-5-4
that is packed against a single a helix at the C terminus (Figure 2).
Significant extended loops project out from the structure and are
stabilized by interactions with the immunity protein in the com-
plex structure. In particular, the loop between strands 1 and 2
also includes a pair of 310 helices and accounts for a full third
of the polypeptide. This somewhat sprawling conformation sug-
gests that Tse2 has regions with high flexibility, which is in
contrast to the structures other T6SS effectors adopt in compact
globular folds (Benz et al., 2012; Dong et al., 2013; Srikannatha-
san et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang
et al., 2013).ights reserved
Figure 1. The Structure of Tse2 and Tsi2
Complex
(A) Cartoon representation of the Tse2/Tsi2 heter-
otetramer looking down the two-fold axis of sym-
metry. The dimer of immunity protein molecules
(Tsi2, green/cyan) is able to bind two toxin mole-
cules (Tse2, purple). The dimensions of the heter-
otetramer are indicated.
(B) A heterotrimer portion of the Tse2/Tsi2 complex
(top; Tse2, purple; Tsi2, green and cyan) with the
interface of this dimer opened along the vertical
plane (shown by the dashed line) to expose the
interacting surfaces of Tsi2 and Tse2 (bottom left
and right, respectively). The surfaces are colored
by electrostatic potential.
(C) The hydrogen bonding network of the two in-
terfaces highlighting the contributing residues.
(D) Details of the primary interface with coloring as
in (A).
(E) Details of the secondary interface with coloring
as in (A).We compared the structure of Tse2 with existing structures in
the databases by a Dali structure similarity search (Holm and
Sander, 1998). The structures returned as most similar were
nicotinamide adenine dinucleotide (NAD)-dependent enzymes
from bacteria, notably the mono-ADP-ribosyltransferase toxins
(ADPRTs). Themost similar protein structure foundwas the diph-
theria toxin (PDB: 1SGK) with a Z score of 4.3, an rmsd of 3.8 A˚
over 91matchedCa atoms, and 10%amino acid sequence iden-
tity (Bell and Eisenberg, 1997). The structural identity between
the diphtheria toxin (535 amino acids) and Tse2 (155 amino
acids) was primarily limited to the five-stranded b sheet at the
core of both folds (see below). The lack of greater structural iden-
tity with other available structures indicates that the remaining
arrangement of loops and the a helix in Tse2 creates an overall
fold that is presently unique to the structural family of toxins to
which Tse2 belongs.
ADPRTs, which transfer ADP-ribose to target molecules
thereby inactivating them, are most commonly divided into two
groups based on different subsets of catalytic residues: the
cholera toxin and the diphtheria toxin groups (Holbourn et al.,
2006). The cholera toxin group has the consensus sequenceStructure 24, 277–284, February 2, 2016Arg, Ser-Thr-Ser, and Glu-X-Glu while
the diphtheria toxin group has consensus
His, Tyr-X10-Tyr, and Glu. The diphtheria
toxin itself was the most similar protein
structure to Tse2 while the most structur-
ally similar ADPRT from the cholera toxin
group was HopU (PDB: 3UOJ), a T3SS
effector from Pseudomonas syringae
(Z score 2.7, rmsd of 3.5 A˚ over 69
matched Ca atoms, and 14% amino
acid sequence identity) (Jeong et al.,
2011). The structural motif shared be-
tween Tse2 and ADP-ribosyltransferases
is the characteristic b sheet of this family
of toxins (Figure 3A). This structural
element houses the catalytic machinery
of these toxins while the regions sur-rounding this structural core differ between the toxins, contrib-
uting to wide sequence variation among ADPRTs (Fieldhouse
and Merrill, 2008). In addition to sharing the b sheet, three puta-
tive catalytic residues were also structurally conserved between
the cholera toxin group of ADPRTs and Tse2 (Figures 3A and 3B).
The residues Arg-14 and Ser-80 from Tse2 are structurally equiv-
alent to Arg-128 and Ser-174 from C3 from Clostridium
botulinum. However, one catalytic residue shared between the
two main groups of ADPRTs is a glutamate (Glu-214 in C3) that
in Tse2 is replaced in the structure by His-122 (Figure 3C). The
protein ranked second most similar to Tse2 was an NAD-depen-
dent tRNA phosphotransferase (Z score 3.6, rmsd of 3.4 A˚ for
73 matched Ca atoms, and 12% amino acid sequence
identity) (Kato-Murayama et al., 2005). The reaction catalyzed
by this enzyme results in the overall transfer of phosphate
from the nascent tRNA to ADP-ribose with loss of the nicotin-
amide group from NAD. This family of proteins is involved in
the last step of tRNA maturation and is thought to bind NAD in
a manner analogous to the diphtheria toxin. An alignment of
Tse2, the two groups of ADPRTs, and the tRNA phospho-
transferase reveals partial active-site conservation between theª2016 Elsevier Ltd All rights reserved 279
Figure 2. The Structure of Tse2 from the
Complex
The structure is shown as a cartoon colored blue
to red from the N terminus to the C terminus. The
secondary structure elements of Tse2 are labeled
sequentially by type. The dimensions of the Tse2
monomer are indicated.phosphotransferase, ADPRTs, and Tse2 (Figure 3C). In the tRNA
phosphotransferase the conserved ADPRT glutamate is re-
placed with a valine, whereas in Tse2 this position is occupied
by a histidine.
Identification of a Putative Active Site
Our structural comparisons of Tse2 with NAD-dependent pro-
teins predict that the set of residues in Tse2 (Arg-14, Ser-80,
His-122) that are structurally conserved with the catalytic resi-
dues in the NAD-dependent enzymes have a role in the toxicity
of Tse2. To test this hypothesis, we performed structure-guided
mutagenesis to generate alanine substitution mutations for Arg-
14, Ser-80, and His-122. Due to its proximity to His-122, we also
mutated Asp-112 (Figure 3A). We compared the growth of E. coli
expressing the wild-type and mutant Tse2 genes, which were
under isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible
T7 RNA polymerase control, in the presence or absence of the
inducer. E. coli expressing wild-type Tse2 was unable to grow
in the presence of IPTG, but in the absence of IPTG grew the
same as the control culture expressing Tsi2, which had the
same growth properties with andwithout the inducer (Figure 3D).
The growth of the strains expressing Tse2 with the mutations
R14A, S80A, and H122A were the same as the uninduced
wild-type and Tsi2 cultures, regardless of whether IPTG was
added to cultures or not. Under the conditions to induce expres-
sion of the D112A mutant protein we observed a reduction of
growth, but not as profound a reduction as when native Tse2 is
expressed (Figure 3D). To demonstrate the level of expression
of the Tse2 mutated proteins, we performed western blotting.
The three Tse2 variants that showed a reversal of the growth
defect were produced in a soluble form indicating that they are
non-toxic, whereas Tse2 and Tse2 D112A were not detectable,
consistent with the nearly complete lack of growth of these
strains (Figure 3E).
DISCUSSION
Determination of the Tse2/Tsi2 complex structure showed Tse2
to possess a b-sheet platform that is structurally conserved with
ADPRTs and tRNA phosphotransferases. Notably, this structural280 Structure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All rights reservedfeature also acts as the support for the
catalytic centers of these NAD-depen-
dent enzymes, which is largely also
conserved in Tse2. The abrogation of
toxicity for the R14A, S80A, and H122A
mutant Tse2 proteins indicates the
importance of these amino acids in the
mechanism of Tse2 toxicity and, given
their conservation with NAD-reactive en-
zymes, also supports their assignmentas being involved in a catalytic reaction the we propose involves
NAD. Asp-112 lies beside the putative catalytic His-122 and
could contribute to catalysis, but appears to be dispensable
for full toxicity of Tse2. Notably, when the amino acid sequence
conservation among Tse2 homologs is mapped onto the surface
of the Tse2 structure, the region containing the these functionally
important putative catalytic residues and, indeed, many of the
residues around the putative catalytic center are highly
conserved (Figure 3F). That these residues are conserved
throughout the Tse2 family points to the general importance of
these amino acids and likely common function for these family
members.
The deployment of such a highly toxic molecule requires that
the bacterium protect itself from Tse2, which P. aeruginosa
does using the Tsi2 anti-toxin. The large buried surface area of
the Tse2/Tsi2 complex suggests a tight interaction between
the two components when forming the inhibited heterotetramer.
Notably, the cleft housing the putative catalytic residues of Tse2
sits directly between the primary and secondary Tse2/Tsi2
binding interfaces and is completely occluded upon binding
the formation of the complex, providing a simple molecular-level
explanation for the efficient means of Tsi2 inhibiting the effects of
Tse2 on the donor cell. Unlike the residues at the putative cata-
lytic center, the majority of surface-exposed amino acids on
Tse2 that are involved in binding Tsi2 shows are not conserved
among the Tse2 family (compare Figures 3F and 3G). This im-
plies that the recognition of the toxin by anti-toxin is species
dependent, in keeping with the concept that this is a specific
form of self-recognition to prevent self-intoxication.
The secreted chaperone Hcp is needed for the intracellular
stability of Tse2 in P. aeruginosa, and evidence indicates that it
is likely bound to the interior of the Hcp ring (Silverman et al.,
2013). The Tse2/Tsi2 heterotetramer is a lozenge shape that is
93 A˚ long and 41 A˚ in diameter (Figure 1A) and thus may
thread lengthwise into the 46-A˚ diameter central cavity of the
Hcp hexameric ring. However, this possible mode of chaper-
oning the inactive Tse2/Tsi2 heterotetramer necessitates that
there be a mechanism for the segregation of Tse2 and Tsi2 dur-
ing the secretion process so that active Tse2may be delivered to
the recipient cell. This is formally possible, but we find it unlikely
Figure 3. Identification of the Active Site of Tse2
(A) An overlay of Tse2 in green and C3 toxin from Clostridium botulinum is shown with the conserved catalytic residues highlighted (Me´ne´trey et al., 2002).
(B) An overlay of the kinked b-sheet motif of Tse2 and C3 toxin with conserved residues and co-factor shown for reference.
(C) A focused structure-based sequence alignment of structurally related proteins from the Dali server. Representative structures from the cholera toxin-type
ADP-ribosyltransferases and Tse2 are highlighted in blue. The alignment includes structures of HopU from Pseudomonas syringae, pertussis toxin from
Bordetella pertussis, and exoenzyme C3 from Clostridium limosum (Hazes et al., 1996; Tsuge et al., 2008; Vogelsgesang et al., 2008; Jeong et al., 2011).
(legend continued on next page)
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given the large amounts of energy that would likely be required to
dissociate the Tse2/Tsi2 heterotetramer. The heterotetrameric
arrangement of the Tse2/Tsi2 toxin-anti-toxin complex is remi-
niscent of the quaternary structure formed by two other T6SS
toxin-anti-toxin pairs (Yang et al., 2014; Zhang et al., 2013). In
these cases, the high affinity of complex formation represented
a dead end for the toxins. Thus, we favor the concept that that
the inhibited form of Tse2 found in the crystal structure repre-
sents a secretion-incompetent form and that Hcp is responsible
for chaperoning the Tse2 monomer. The length and diameter of
the folded Tse2 monomer are 52 A˚ and 41 A˚ (Figure 2),
respectively, and therefore of appropriate size to essentially fill
the center of the Hcp ring, as was observed in electron micro-
scopy studies by Silverman et al. (2013). The structural features
of Tse2 are consistent with a mechanism of toxicity that is NAD
dependent and may provide ADP-ribosyltransferase activity,
although this remains to be conclusively determined. This poten-
tial activity, which parallels the cytotoxin effectors of the type III
secretion system (Deng and Barbieri, 2008), distinguishes Tse2
from other T6SS effectors and, with an appropriately conserved
targetmolecule, would explain the ability of Tse2 to act as a cyto-
toxin toward both prokaryotic and eukaryotic cells.
EXPERIMENTAL PROCEDURES
Cloning, Production, Purification, Crystallization, and Structure
Solving
The genes for Tse2 and Tsi2 (PA2702, PA2703) were cloned into pET28 by
amplifying the complete open reading frame of each gene (encoding residues
1–158 and 1–77) using genomic P. aeruginosa PAO1 DNA (ATCC 47085D-5)
and appropriate primers (Table S1). These amplicons were digested with
appropriate restriction enzymes and ligated into pET-28 or pET-22b making
pET28-Tse2, pET22-Tse2, and pET28-Tsi2. For co-expression, Tse2 was re-
amplified from pET28-Tse2 including the N-terminal His-tag and thrombin
cleavage site, digested, and ligated into the NcoI-NotI site of pETDUET. This
vector was re-digested and Tsi2 was ligated into the second multiple cloning
site at the NdeI-XhoI site to generate the complete vector pETDUET-Tse2Tsi2.
BL21 (DE3) harboring respective vectors were grown in LB medium supple-
mented with kanamycin or ampicillin. The cultures were grown at 37C for
6 hr and induced at 16C for 16 hr with 0.5 mM IPTG, cells harvested by centri-
fugation, and chemically lysed (Robb et al., 2012). Protein was purified from
clarified by immobilized metal affinity chromatography, exchanged by dialysis
into 20 mM Tris (pH 8.0) and 150 mM NaCl, and concentrated to 10 mg/ml for
crystallization. Crystals were obtained by the hanging-drop vapor diffusion
method in 20 mM Tris (pH 8.5), 0.2 M NaCl, and 22% polyethylene glycol
4000. Crystals were cryo-protected in crystallization solution supplemented
with 25% ethylene glycol and placed directly in a cryo stream at 113 K.
A diffraction dataset was collected at a wavelength of 1 A˚. Data processing
was carried out in XDS and SCALA from the CCP4 package in the space group
P212121. The structure was solved by molecular replacement searching for
two Tsi2 monomers (PDB: 3VPV) using Phaser-MR. Autobuilding was carriedHighlighted in purple, the diphtheria toxin, exotoxin A from Pseudomonas aeru
comparison (Bennett and Eisenberg, 1994; Kato-Murayama et al., 2005; Wedekin
the alignment. The residues that line the putative catalytic site of Tse2 that were
known to be catalytic residues in the ADP-ribosylating toxins.
(D) Growth curves of E. coli harboring plasmids that carry Tse2, Tse2 mutants, or T
in red for each strain. The dashed lines show the SD of triplicate measurements.
(E) A western blot probing for histidine-tagged Tse2 from E. coli samples from th
(F) Sequence conservation mapped onto the structure of Tse2. The colors of th
mutated residues from the toxicity experiments are highlighted. Sequence alignm
(G) The structure of Tse2 with the surfaces forming the binding interface with Tsi2
See also Figure S1.
282 Structure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All rout in Phenix and resulted in a nearly complete model (Adams et al., 2010).
Rounds of restrained refinement in Refmac and manual building in Coot
were used to complete the model (Emsley et al., 2010; Murshudov et al.,
2011). Structure validation was carried out using MolProbity, and Ramachan-
dran statistics were taken from this analysis (Chen et al., 2010). The coordi-
nates and structure factors have been deposited in the PDB (PDB: 5AKO).
Mutagenesis and Toxicity Experiments
Mutagenesis of the putative active site was performed as previously described
(Liu and Naismith, 2008). In brief, partially overlapping oligonucleotides were
used to amplify by PCR the entire pET28-Tse2 plasmid, which was then trans-
formed into competent E. coli DH5a (Table S1). The point mutations were
confirmed by sequencing.
E. coli BL21 (DE3) pLysS cells were transformed with either pET28-Tse2,
mutants of pET28-Tse2, or pET28-Tsi2. Starter cultures were grown for 6 hr
in LB medium at 37C with shaking before being diluted 25 times in 250 ml of
medium in triplicate in a 96-well tray. The trays were incubated 37C with pe-
riodic shaking in the plate reader (5 s every 15 min). Measurements of absor-
bance at 595 nm were collected every 15 min for 8 hr. Growth was measured
for each strain with or without 1 mM IPTG. Cells were resuspended in Laemmli
buffer and heated to 90C for 30min. Samples were centrifuged and separated
by SDS-PAGE on a 15% polyacrylamide gel. Following electrophoresis, the
samples were transferred to nitrocellulose at 30 V for 1 hr. The nitrocellulose
membrane was blocked using 5% milk in PBS with 1% Tween 20 (PBS-T)
overnight at 16C. The blocked membrane was probed with rabbit polyclonal
immunoglobulin G against polyhistidine (Santa Cruz Biotechnology) in PBS-T
with 1% milk for 1 hr at room temperature. After washing, a goat anti-rabbit
monoclonal with a fluorescent dye was applied in PBS-T with 1% milk for
1 hr at room temperature. The membrane was scanned at 700 and 800 nm
to measure the fluorescence.
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